- Home
- CYRX vs BDN Comparison
CYRX vs BDN Comparison
Compare CYRX & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | BDN |
|---|---|---|
| Founded | 1999 | 1986 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.3M | 482.9M |
| IPO Year | 2008 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CYRX | BDN |
|---|---|---|
| Price | $7.96 | $2.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | ★ $12.94 | $4.00 |
| AVG Volume (30 Days) | 425.4K | ★ 2.7M |
| Earning Date | 03-03-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 12.31% |
| EPS Growth | ★ 156.22 | 9.65 |
| EPS | ★ 1.40 | N/A |
| Revenue | $176,177,000.00 | ★ $484,454,000.00 |
| Revenue This Year | $10.92 | $16.89 |
| Revenue Next Year | $8.08 | $1.21 |
| P/E Ratio | $5.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.63 | $2.59 |
| 52 Week High | $11.45 | $4.63 |
Technical Indicators
Market Signals| Indicator | CYRX | BDN |
|---|---|---|
| Relative Strength Index (RSI) | 42.35 | 23.01 |
| Support Level | $6.57 | N/A |
| Resistance Level | $8.52 | $3.16 |
| Average True Range (ATR) | 0.39 | 0.09 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 28.43 | 0.98 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.